Johns Hopkins ABX Guide
Tobramycin
Tobramycin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- UTI
- Septicemia, including serious central nervous system infections (use in combination)
- Lower respiratory tract infections (use in combination)
- Complicated urinary tract infections
- Intra-abdominal infections, including peritonitis (use in combination)
- Skin, bone, and skin structure infections (use in combination)
- Management of cystic fibrosis, with P. aeruginosa (as TOBI inhalation)
- Treatment of ocular infections (uncomplicated conjunctivitis-ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Pseudomonal infections (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, carbapenem or a third/fourth-generation cephalosporin)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- UTI
- Septicemia, including serious central nervous system infections (use in combination)
- Lower respiratory tract infections (use in combination)
- Complicated urinary tract infections
- Intra-abdominal infections, including peritonitis (use in combination)
- Skin, bone, and skin structure infections (use in combination)
- Management of cystic fibrosis, with P. aeruginosa (as TOBI inhalation)
- Treatment of ocular infections (uncomplicated conjunctivitis-ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Pseudomonal infections (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, carbapenem or a third/fourth-generation cephalosporin)
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: November 2, 2015
Citation
Pham, Paul A, and John G Bartlett. "Tobramycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2015. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540556/all/Tobramycin.
Pham PA, Bartlett JG. Tobramycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540556/all/Tobramycin. Accessed March 1, 2021.
Pham, P. A., & Bartlett, J. G. (2015). Tobramycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540556/all/Tobramycin
Pham PA, Bartlett JG. Tobramycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. [cited 2021 March 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540556/all/Tobramycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tobramycin
ID - 540556
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2015/11/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540556/all/Tobramycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
